ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells.

Ming Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.